<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biologics License Application on FinanClub</title>
    <link>https://finan.club/tags/biologics-license-application/</link>
    <description>Recent content in Biologics License Application on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 21 Dec 2023 09:04:45 +0000</lastBuildDate><atom:link href="https://finan.club/tags/biologics-license-application/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>IBRX</title>
      <link>https://finan.club/us/ibrx/</link>
      <pubDate>Thu, 21 Dec 2023 09:04:45 +0000</pubDate>
      
      <guid>https://finan.club/us/ibrx/</guid>
      <description>score:268
Chances: ImmunityBio, Inc. is participating in the 35th Annual Piper Sandler Healthcare Conference, which may provide an opportunity for the company to showcase its potential for investors and stakeholders. New data showing promising results with Memory Cytokine-Enriched Natural Killer cells (M-ceNK) indicates a potential breakthrough in treating small cell lung cancer and other neuroendocrine tumors, presenting a chance for significant revenue growth if these treatments prove successful in clinical trials.</description>
    </item>
    
  </channel>
</rss>
